ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 675254 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 675254; 2) Community: the network communities that were significantly associated with the response to NSC 675254; 3) Molecule: the relationships between components within communities and NSC 675254; 4) MDR: the compounds that were significantly associated with the NSC 675254.

NSC Compound Enrichment Correlation
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0342636096654271 0.095261486
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0342636096654271 0.12838398
NSC 400938 Null 0.0342636096654271 0.24177514
NSC 48300 ANTINEOPLASTIC-48300 0.0342636096654271 0.4647758
NSC 610456 Camptothecin Derivative 0.0342636096654271 0.15575048
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0342636096654271 0.23752277
NSC 632604 Bis-p-tolylediselenide 0.0342636096654271 0.27660757
NSC 634724 10,11-methylenedioxycamptothecin 0.0342636096654271 0.11834633
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0342636096654271 0.2263659
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0342636096654271 0.17387599
Total:83  Current:51    [First] [Prev] [Next] [Last]